Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
43
BODI Quote, Financials, Valuation and Earnings
Last price:
$10.65
Seasonality move
:
-7.62%
Day range:
$11.06 - $12.33
52-week range:
$3.38 - $12.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.28x
P/B ratio:
3.24x
Volume:
125.7K
Avg. volume:
455.9K
1-year change:
82.85%
Market cap:
$80.1M
Revenue:
$418.8M
EPS (TTM):
-$6.22
Analysts' Opinion
-
Consensus RatingThe Beachbody Co., Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $10.17, The Beachbody Co., Inc. has an estimated downside of -10.03% from its current price of $11.30.
-
Price Target UpsideAccording to analysts, the highest upside price target is $15.00 representing -100% upside increase from its current price of $11.30.
Fair Value
-
According to the consensus of 3 analysts, The Beachbody Co., Inc. has -10.03% downside to fair value with a price target of $10.17 per share.
BODI vs. S&P 500
-
Over the past 5 trading days, The Beachbody Co., Inc. has underperformed the S&P 500 by -2.52% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Beachbody Co., Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Beachbody Co., Inc. revenues have been falling on a year-over-year basis for 17 quarters in a row. In the most recent quarter The Beachbody Co., Inc. reported revenues of $59.9M.
Earnings Growth
-
The Beachbody Co., Inc. has grown year-over-year earnings for 7 quarters straight. In the most recent quarter The Beachbody Co., Inc. reported earnings per share of $0.51.
Enterprise value:
67.4M
EV / Invested capital:
1.34x
Price / LTM sales:
0.28x
EV / EBIT:
--
EV / Revenue:
0.24x
PEG ratio (5yr expected):
--
EV / Free cash flow:
11.67x
Price / Operating cash flow:
13.58x
Enterprise value / EBITDA:
3.83x
Gross Profit (TTM):
$188.8M
Return On Assets:
-25.23%
Net Income Margin (TTM):
-15.09%
Return On Equity:
-137.16%
Return On Invested Capital:
-77.93%
Operating Margin:
8.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $556.3M | $451.4M | $282.6M | $102.2M | $59.9M | |
| Gross Profit | $302.3M | $279.3M | $188.8M | $62.9M | $43.7M | |
| Operating Income | -$103M | -$43.8M | -$11.9M | -$7.9M | $5M | |
| EBITDA | -$33.5M | $2.9M | $17.6M | $3.9M | $8.8M | |
| Diluted EPS | -$21.39 | -$15.76 | -$6.22 | -$1.75 | $0.51 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $372.6M | $177.6M | $93.6M | $65.7M | $57.1M | |
| Total Assets | $858.8M | $498.6M | $347.3M | $225.5M | $146.4M | |
| Current Liabilities | $277.7M | $192.8M | $172.8M | $148.6M | $93.1M | |
| Total Liabilities | $333.2M | $246.3M | $206.3M | $167.1M | $121.7M | |
| Total Equity | $525.6M | $252.3M | $141.1M | $58.4M | $24.7M | |
| Total Debt | $33.8M | $40.7M | $30.7M | $23.6M | $24.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$24.8M | $1.3M | $10M | $1.1M | $10.2M | |
| Cash From Investing | -$13M | $549K | -$4.3M | -$1M | -$1.2M | |
| Cash From Financing | -$18.4M | -$7.8M | -$3.5M | -$306K | -$274K | |
| Free Cash Flow | -$33.6M | -$3.7M | $5.8M | $53K | $9M | |
BODI
Sector
Market Cap
$80.1M
$324.3M
Price % of 52-Week High
91.65%
73.5%
Dividend Yield
0%
0%
Shareholder Yield
-0.82%
1.99%
1-Year Price Total Return
82.85%
-2.95%
Beta (5-Year)
--
0.537
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$11.32
200-day SMA
Buy
Level
$5.68
Bollinger Bands (100)
Buy
Level
4.4 - 8.74
Chaikin Money Flow
Buy
Level
296.1K
20-day SMA
Buy
Level
$10.46
Relative Strength Index (RSI14)
Buy
Level
62.52
ADX Line
Buy
Level
47
Williams %R
Neutral
Level
-35.7639
50-day SMA
Buy
Level
$7.56
MACD (12, 26)
Buy
Level
1.12
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
11.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-3.8233)
Sell
CA Score
(Annual)
Level (-1.6679)
Buy
Beneish M-Score
(Annual)
Level (-4.3072)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (5.8525)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Beachbody Co., Inc. operates as a health and wellness company. It offers holistic health and wellness platforms. The company's product offerings include digital subscriptions, nutritional products, and connected fitness products. Digital subscriptions include Beachbody On Demand (BOD) and Openfit. The subscriptions are renewed on a monthly, quarterly, or annual basis and include unlimited access to a library of live and on-demand fitness and nutrition content. Nutritional products include Shakeology, Beachbody Performance supplements, BEACHBARs, and others. Connected fitness products include The Beachbody Bike (also known as Myx), which is equipped with a swivel touch screen that enables users to engage with content beyond the indoor cycling experience and encourages broader cross-training, incorporating resistance training and yoga for a more holistic fitness experience and healthier results. The company was founded by Carl Daikeler and Jon Congdon in 1998 and is headquartered in El Segundo, CA.
Stock Forecast FAQ
In the current month, BODI has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The BODI average analyst price target in the past 3 months is $10.17.
-
Where Will The Beachbody Co., Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Beachbody Co., Inc. share price will drop to $10.17 per share over the next 12 months.
-
What Do Analysts Say About The Beachbody Co., Inc.?
Analysts are divided on their view about The Beachbody Co., Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Beachbody Co., Inc. is a Sell and believe this share price will rise from its current level to $6.50.
-
What Is The Beachbody Co., Inc.'s Price Target?
The price target for The Beachbody Co., Inc. over the next 1-year time period is forecast to be $10.17 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BODI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Beachbody Co., Inc. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BODI?
You can purchase shares of The Beachbody Co., Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Beachbody Co., Inc. shares.
-
What Is The The Beachbody Co., Inc. Share Price Today?
The Beachbody Co., Inc. was last trading at $10.65 per share. This represents the most recent stock quote for The Beachbody Co., Inc.. Yesterday, The Beachbody Co., Inc. closed at $11.30 per share.
-
How To Buy The Beachbody Co., Inc. Stock Online?
In order to purchase The Beachbody Co., Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BODI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BODI
Sector
P/E ratio
--
17.45x
PEG ratio
--
0.11x
P/B ratio
3.24x
1.33x
Price / LTM sales
0.28x
0.58x
Growth Metrics
BODI
Sector
Revenue growth
-41.4%
3.54%
Earnings growth
128.87%
--
Revenue (5-year growth)
-11.14%
3.17%
Earnings forecast
-$1.30
$0.25
Profitability
BODI
Sector
Profitability FY 2024
$264M
$298.2M
Return on invested capital
-77.93%
3.41%
Return on assets
-25.23%
2.25%
Return on equity
-137.16%
5.88%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Mar
26
Estimated Next Earnings Date
Feb
9
Balance Sheet
BODI
Sector
Total cash
$38.2M
$130M
Short term investments
--
$41M
Total assets
$174.6M
$1.1B
Long term debt
$24.4M
$36M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
